MD SB384 | 2013 | Regular Session
Status
Sponsorship: Moderate Partisan Bill (Democrat 22-4)
Status: Engrossed on February 27 2013 - 50% progression, died in committee
Action: 2013-03-26 - Hearing 3/26 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on February 27 2013 - 50% progression, died in committee
Action: 2013-03-26 - Hearing 3/26 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Establishing the Sickle Cell Disease Research Program to be administered by the Maryland Technology Development Corporation to provide grants for sickle cell disease research projects; establishing the purposes of the Program; establishing specified types of grants to be awarded under the Program; establishing the Sickle Cell Disease Research Fund in the Corporation; providing for the purpose and composition of the Fund; etc.
Title
Economic Development - Sickle Cell Disease Research Program
Sponsors
Roll Calls
2012-02-27 - Senate - Senate Floor - Third Reading Passed (47-0) (Y: 47 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2013-03-26 | House | Hearing 3/26 at 1:00 p.m. |
| 2013-02-28 | House | First Reading Health and Government Operations |
| 2013-02-27 | Senate | Third Reading Passed (47-0) |
| 2013-02-25 | Senate | Second Reading Passed with Amendments |
| 2013-02-25 | Senate | Favorable with Amendments {847876/1 Report Adopted |
| 2013-02-22 | Senate | Laid Over (Senator Madaleno) Adopted |
| 2013-02-22 | Senate | Favorable with Amendments {847876/1 |
| 2013-02-21 | Senate | Favorable with Amendments Report by Finance |
| 2013-02-12 | Senate | Hearing 2/12 at 1:00 p.m. |
| 2013-01-25 | Senate | First Reading Finance |
Subjects
Appropriations
Commerce and Business
Diseases
Economic and Community Development
Grants
Industry and Technology
Loans
Medical Research
Public Corporations and Instrumentalities
Reports
Revenue and Taxes
Rules and Regulations
Commerce and Business
Diseases
Economic and Community Development
Grants
Industry and Technology
Loans
Medical Research
Public Corporations and Instrumentalities
Reports
Revenue and Taxes
Rules and Regulations
